Pular para o conteúdo principal
Ranking Invest

ANIK - Anika Therapeutics, Inc.

Segmento: HealthcareAnika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Análise Ranking Invest

Valuation estimado
-$ 3.68 Mi
Valor de Mercado
$ 278.90 Mi
Desconto (AV)-7671.6%
IVR
-0.01A companhia vale -0,01 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.52O valuation alternativo equivale a -52% do valor de mercado da companhia.
MLL
-0.52O lucro líquido dos controladores em 16 trimestres equivale a -52% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 137.28 Mi

Dívida Líquida

-$ 38.41 Mi

L4T

-$ 3.78 Mi

MM4T

-3.59%

Indicadores Básicos

ROE

-2.76%

Índices de Previsibilidade

Receita Líquida

D0.10

Lucro

D0.90

Margem

D1.01

Índices de Tendência

Receita Líquida

F-9.42

Lucro

C2.18

Margem

C2.31

Índices de Endividamento

DIV/PAT

-0.28

DIV/L4T

10.15

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.